Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Acne medication industry 360° synopsis, 2018 - 2032
2.2 Business trends
2.2.1 Formulation trends
2.2.2 Product trends
2.2.3 Type trends
2.2.4 Acne type trends
2.2.5 Distirbution channel trends
2.2.6 Regional trends
Chapter 3 Acne Medication Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of severe acne problems
3.3.1.2 Growing awareness regarding the acne treatment options
3.3.1.3 Rising concern for facial aesthetics
3.3.2 Industry pitfalls & challenges
3.3.2.1 Side-effects associated with acne medication
3.3.2.2 Entry of generic products
3.4 Growth potential analysis
3.4.1 By formulation
3.4.2 By product
3.4.3 By type
3.4.4 By acne type
3.4.5 By distribution channel
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Consumer trends
3.8 Merger and acquisition landscape
3.9 Gap analysis
3.10 Porter's Analysis
3.11 PESTLE Analysis
Chapter 4 Competitive landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021
Chapter 5 Acne Medication Market, By Formulation
5.1 Key segment trends
5.2 Topical
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Oral
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Acne Medication Market, By Product
6.1 Key segment trends
6.2 Retinoids
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Antibiotics
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Salicylic acid
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Benzoyl peroxide
6.5.1 Market size, by region, 2018 - 2032 (USD Million)
6.6 Azelaic acid
6.6.1 Market size, by region, 2018 - 2032 (USD Million)
6.7 Others
6.7.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Acne Medication Market, By Type
7.1 Key segment trends
7.2 Prescription
7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 OTC
7.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Acne Medication Market, By Acne Type
8.1 Key segment trends
8.2 Inflammatory acne
8.2.1 Market size, by region, 2018 - 2032 (USD Million)
8.3 Non-inflammatory acne
8.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 9 Acne Medication Market, By Distribution Channel
9.1 Key segment trends
9.2 Retail Stores
9.2.1 Market size, by region, 2018 - 2032 (USD Million)
9.3 Pharmacies & Drug Stores
9.3.1 Market size, by region, 2018 - 2032 (USD Million)
9.4 E-commerce
9.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 10 Acne Medication Market, By Region
10.1 Key regional trends
10.2 North America
10.2.1 Market size, by country, 2018 - 2032 (USD Million)
10.2.2 Market size, by formulation, 2018 - 2032 (USD Million)
10.2.3 Market size, by product, 2018 - 2032 (USD Million)
10.2.4 Market size, by type, 2018 - 2032 (USD Million)
10.2.5 Market size, by acne type, 2018 - 2032 (USD Million)
10.2.6 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.2.7 U.S.
10.2.7.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.2.7.2 Market size, by product, 2018 - 2032 (USD Million)
10.2.7.3 Market size, by type, 2018 - 2032 (USD Million)
10.2.7.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.2.7.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.2.8 Canada
10.2.8.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.2.8.2 Market size, by product, 2018 - 2032 (USD Million)
10.2.8.3 Market size, by type, 2018 - 2032 (USD Million)
10.2.8.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.2.8.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.3 Europe
10.3.1 Market size, by country, 2018 - 2032 (USD Million)
10.3.2 Market size, by formulation, 2018 - 2032 (USD Million)
10.3.3 Market size, by product, 2018 - 2032 (USD Million)
10.3.4 Market size, by type, 2018 - 2032 (USD Million)
10.3.5 Market size, by acne type, 2018 - 2032 (USD Million)
10.3.6 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.3.7 Germany
10.3.7.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.3.7.2 Market size, by product, 2018 - 2032 (USD Million)
10.3.7.3 Market size, by type, 2018 - 2032 (USD Million)
10.3.7.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.3.7.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.3.8 UK
10.3.8.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.3.8.2 Market size, by product, 2018 - 2032 (USD Million)
10.3.8.3 Market size, by type, 2018 - 2032 (USD Million)
10.3.8.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.3.8.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.3.9 France
10.3.9.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.3.9.2 Market size, by product, 2018 - 2032 (USD Million)
10.3.9.3 Market size, by type, 2018 - 2032 (USD Million)
10.3.9.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.3.9.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.3.10 Spain
10.3.10.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.3.10.2 Market size, by product, 2018 - 2032 (USD Million)
10.3.10.3 Market size, by type, 2018 - 2032 (USD Million)
10.3.10.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.3.10.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.3.11 Italy
10.3.11.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.3.11.2 Market size, by product, 2018 - 2032 (USD Million)
10.3.11.3 Market size, by type, 2018 - 2032 (USD Million)
10.3.11.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.3.11.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.4 Asia Pacific
10.4.1 Market size, by country, 2018 - 2032 (USD Million)
10.4.2 Market size, by formulation, 2018 - 2032 (USD Million)
10.4.3 Market size, by product, 2018 - 2032 (USD Million)
10.4.4 Market size, by type, 2018 - 2032 (USD Million)
10.4.5 Market size, by acne type, 2018 - 2032 (USD Million)
10.4.6 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.4.7 China
10.4.7.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.4.7.2 Market size, by product, 2018 - 2032 (USD Million)
10.4.7.3 Market size, by type, 2018 - 2032 (USD Million)
10.4.7.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.4.7.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.4.8 Japan
10.4.8.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.4.8.2 Market size, by product, 2018 - 2032 (USD Million)
10.4.8.3 Market size, by type, 2018 - 2032 (USD Million)
10.4.8.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.4.8.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.4.9 India
10.4.9.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.4.9.2 Market size, by product, 2018 - 2032 (USD Million)
10.4.9.3 Market size, by type, 2018 - 2032 (USD Million)
10.4.9.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.4.9.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.4.10 Australia
10.4.10.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.4.10.2 Market size, by product, 2018 - 2032 (USD Million)
10.4.10.3 Market size, by type, 2018 - 2032 (USD Million)
10.4.10.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.4.10.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.4.11 South Korea
10.4.11.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.4.11.2 Market size, by product, 2018 - 2032 (USD Million)
10.4.11.3 Market size, by type, 2018 - 2032 (USD Million)
10.4.11.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.4.11.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.5 Latin America
10.5.1 Market size, by country, 2018 - 2032 (USD Million)
10.5.2 Market size, by formulation, 2018 - 2032 (USD Million)
10.5.3 Market size, by product, 2018 - 2032 (USD Million)
10.5.4 Market size, by type, 2018 - 2032 (USD Million)
10.5.5 Market size, by acne type, 2018 - 2032 (USD Million)
10.5.6 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.5.7 Brazil
10.5.7.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.5.7.2 Market size, by product, 2018 - 2032 (USD Million)
10.5.7.3 Market size, by type, 2018 - 2032 (USD Million)
10.5.7.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.5.7.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.5.8 Mexico
10.5.8.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.5.8.2 Market size, by product, 2018 - 2032 (USD Million)
10.5.8.3 Market size, by type, 2018 - 2032 (USD Million)
10.5.8.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.5.8.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.5.9 Argentina
10.5.9.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.5.9.2 Market size, by product, 2018 - 2032 (USD Million)
10.5.9.3 Market size, by type, 2018 - 2032 (USD Million)
10.5.9.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.5.9.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.6 Middle East & Africa
10.6.1 Market size, by country, 2018 - 2032 (USD Million)
10.6.2 Market size, by formulation, 2018 - 2032 (USD Million)
10.6.3 Market size, by product, 2018 - 2032 (USD Million)
10.6.4 Market size, by type, 2018 - 2032 (USD Million)
10.6.5 Market size, by acne type, 2018 - 2032 (USD Million)
10.6.6 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.6.7 South Africa
10.6.7.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.6.7.2 Market size, by product, 2018 - 2032 (USD Million)
10.6.7.3 Market size, by type, 2018 - 2032 (USD Million)
10.6.7.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.6.7.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.6.8 Saudi Arabia
10.6.8.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.6.8.2 Market size, by product, 2018 - 2032 (USD Million)
10.6.8.3 Market size, by type, 2018 - 2032 (USD Million)
10.6.8.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.6.8.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
10.6.9 UAE
10.6.9.1 Market size, by formulation, 2018 - 2032 (USD Million)
10.6.9.2 Market size, by product, 2018 - 2032 (USD Million)
10.6.9.3 Market size, by type, 2018 - 2032 (USD Million)
10.6.9.4 Market size, by acne type, 2018 - 2032 (USD Million)
10.6.9.5 Market size, by distribution channel, 2018 - 2032 (USD Million)
Chapter 11 Company Profiles
11.1 Allergan (AbbVie)
11.1.1 Business Overview
11.1.2 Financial Data
11.1.3 Product Landscape
11.1.4 Strategic Outlook
11.1.5 SWOT Analysis
11.2 Galderma S.A.
11.2.1 Business Overview
11.2.2 Financial Data
11.2.3 Product Landscape
11.2.4 Strategic Outlook
11.2.5 SWOT Analysis
11.3 Reckitt Benckiser Group plc
11.3.1 Business Overview
11.3.2 Financial Data
11.3.3 Product Landscape
11.3.4 Strategic Outlook
11.3.5 SWOT Analysis
11.4 Bausch Health
11.4.1 Business Overview
11.4.2 Financial Data
11.4.3 Product Landscape
11.4.4 Strategic Outlook
11.4.5 SWOT Analysis
11.5 Stiefel Laboratories (GlaxoSmithKline plc)
11.5.1 Business Overview
11.5.2 Financial Data
11.5.3 Product Landscape
11.5.4 Strategic Outlook
11.5.5 SWOT Analysis
11.6 Bayer AG
11.6.1 Business Overview
11.6.2 Financial Data
11.6.3 Product Landscape
11.6.4 Strategic Outlook
11.6.5 SWOT Analysis
11.7 Almirall S.A.
11.7.1 Business Overview
11.7.2 Financial Data
11.7.3 Product Landscape
11.7.4 Strategic Outlook
11.7.5 SWOT Analysis
11.8 Paratek Pharmaceuticals
11.8.1 Business Overview
11.8.2 Financial Data
11.8.3 Product Landscape
11.8.4 Strategic Outlook
11.8.5 SWOT Analysis
11.9 Teva Pharmaceutical Industries
11.9.1 Business Overview
11.9.2 Financial Data
11.9.3 Product Landscape
11.9.4 Strategic Outlook
11.9.5 SWOT Analysis
11.10 Akorn Operating, LLC
11.10.1 Business Overview
11.10.2 Financial Data
11.10.3 Product Landscape
11.10.4 Strategic Outlook
11.10.5 SWOT Analysis
11.11 Sun Pharmaceutical Industries Ltd.
11.11.1 Business Overview
11.11.2 Financial Data
11.11.3 Product Landscape
11.11.4 Strategic Outlook
11.11.5 SWOT Analysis
11.12 Pfizer, Inc.
11.12.1 Business Overview
11.12.2 Financial Data
11.12.3 Product Landscape
11.12.4 Strategic Outlook
11.12.5 SWOT Analysis
11.13 Viatris
11.13.1 Business Overview
11.13.2 Financial Data
11.13.3 Product Landscape
11.13.4 Strategic Outlook
11.13.5 SWOT Analysis
11.14 Mayne Pharmaceuticals
11.14.1 Business Overview
11.14.2 Financial Data
11.14.3 Product Landscape
11.14.4 Strategic Outlook
11.14.5 SWOT Analysis
11.15 Procter & Gamble
11.15.1 Business Overview
11.15.2 Financial Data
11.15.3 Product Landscape
11.15.4 Strategic Outlook
11.15.5 SWOT Analysis
